Stryker Corporation (SYK)
362.87
-0.97 (-0.27%)
At close: Mar 13, 2025, 1:00 PM
-0.27% (1D)
| Bid | 362.83 |
| Market Cap | 138.46B |
| Revenue (ttm) | 22.63B |
| Net Income (ttm) | 3B |
| EPS (ttm) | 7.74 |
| PE Ratio (ttm) | 46.88 |
| Forward PE | 26.35 |
| Analyst | Buy |
| Ask | 363.45 |
| Volume | 605,839 |
| Avg. Volume (20D) | 1,410,112 |
| Open | 364.03 |
| Previous Close | 363.84 |
| Day's Range | 361.03 - 367.28 |
| 52-Week Range | 314.93 - 406.19 |
| Beta | 0.95 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and...
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 17, 1980
Employees 53,000
Stock Exchange NYSE
Ticker Symbol SYK
Website https://www.stryker.com
Analyst Forecast
According to 20 analyst ratings, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $427, which is an increase of 17.67% from the latest price.
Stock ForecastsNext Earnings Release
Stryker Corporation is scheduled to release its earnings on Apr 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-1.19%
Stryker shares are trading lower following Q4 fina...
Unlock content with
Pro Subscription
1 month ago
+3.24%
Stryker shares are trading higher after the company announced it's commencing a tender offer to acquire the outstanding stock of Inari Medical for $80 per share in cash.
